VenoStent Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.6M

  • Investors
  • 27

VenoStent General Information

Description

Developer of a biomedical engineering technology designed to improve the quality and length of life for dialysis patients. The company's technology is made from a new class of shape-memory polymers used primarily as an external stent in coronary artery bypass surgery which requires no sutures, it uses the body's healing mechanisms to mimic the arterial environment in veins, and its net effect is improved AVF usability and durability, and quality and length of life, for chronic kidney disease (CKD) patients, enabling doctors to have a reduction in surgery time, risk of infection, and wound reopening of hemodialysis patients while also reducing failure from vein occlusion.

Contact Information

Website
www.venostent.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2450 Holcombe Boulevard
  • Suite J
  • Houston, TX 77021
  • United States
+1 (832)
Primary Industry
Surgical Devices
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Therapeutic Devices
Other Devices and Supplies
Vertical(s)
3D Printing, HealthTech, Life Sciences
Corporate Office
  • 2450 Holcombe Boulevard
  • Suite J
  • Houston, TX 77021
  • United States
+1 (832)

VenoStent Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VenoStent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Grant 27-Jun-2024 $3.6M Completed Clinical Trials - Phase 3
15. Later Stage VC (Series A) 27-Jun-2024 Completed Clinical Trials - Phase 3
14. Later Stage VC 30-Oct-2023 Completed Clinical Trials - Phase 1
13. Accelerator/Incubator 02-Dec-2021 Completed Pre-Clinical Trials
12. Seed Round 16-Feb-2021 Completed Pre-Clinical Trials
11. Grant 22-Jul-2020 Completed Pre-Clinical Trials
10. Accelerator/Incubator 24-Jun-2020 Completed Pre-Clinical Trials
9. Grant 15-Apr-2020 Completed Pre-Clinical Trials
8. Grant 14-Aug-2019 $745K $400K Completed Pre-Clinical Trials
7. Seed Round 16-Jul-2019 $370K $400K Completed Pre-Clinical Trials
To view VenoStent’s complete valuation and funding history, request access »

VenoStent Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A1
Series A
Seed A-3
Seed A-2
Seed A-1
Seed-2 823,796 $0.000010 $0.25 $0.25 1x $0.25 2.66%
Seed-1 406,502 $0.000010 $0.74 $0.74 1x $0.74 1.31%
To view VenoStent’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

VenoStent Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biomedical engineering technology designed to improve the quality and length of life for dialysis patient
Surgical Devices
Houston, TX
37 As of 2025

Tel Aviv, Israel
 

Cresskill, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VenoStent Competitors (3)

One of VenoStent’s 3 competitors is Laminate Medical Technologies, a Venture Capital-Backed company based in Tel Aviv, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Laminate Medical Technologies Venture Capital-Backed Tel Aviv, Israel
Vascular Therapies Venture Capital-Backed Cresskill, NJ
Humacyte Formerly VC-backed Durham, NC
You’re viewing 3 of 3 competitors. Get the full list »

VenoStent Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

VenoStent Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220257827-A1 Additive manufacturing of vinyl, photocrosslinkable polymers Pending 22-Jul-2019
AU-2020315842-A1 Additive manufacturing of vinyl, photocrosslinkable polymers Pending 22-Jul-2019
CA-3148465-A1 Additive manufacturing of vinyl, photocrosslinkable polymers Pending 22-Jul-2019
EP-4003699-A1 Additive manufacturing of vinyl, photocrosslinkable polymers Pending 22-Jul-2019
EP-4003699-A4 Additive manufacturing of vinyl, photocrosslinkable polymers Pending 22-Jul-2019 C08G63/08
To view VenoStent’s complete patent history, request access »

VenoStent Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VenoStent Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alumni Ventures Venture Capital Minority
Baylor Angel Network Angel Group Minority
Good Growth Capital Venture Capital Minority
National Institutes of Health Government
Norwest Venture Partners Venture Capital Minority
You’re viewing 5 of 27 investors. Get the full list »

Ready to get started?

Request a free trial

VenoStent FAQs

  • When was VenoStent founded?

    VenoStent was founded in 2015.

  • Where is VenoStent headquartered?

    VenoStent is headquartered in Houston, TX.

  • What is the size of VenoStent?

    VenoStent has 37 total employees.

  • What industry is VenoStent in?

    VenoStent’s primary industry is Surgical Devices.

  • Is VenoStent a private or public company?

    VenoStent is a Private company.

  • What is VenoStent’s current revenue?

    The current revenue for VenoStent is .

  • How much funding has VenoStent raised over time?

    VenoStent has raised $22.8M.

  • Who are VenoStent’s investors?

    Alumni Ventures, Baylor Angel Network, Good Growth Capital, National Institutes of Health, and Norwest Venture Partners are 5 of 27 investors who have invested in VenoStent.

  • Who are VenoStent’s competitors?

    Laminate Medical Technologies, Vascular Therapies, and Humacyte are competitors of VenoStent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »